Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiharu Tsubakihara

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Seminars in Dialysis|June 21, 2011
Limiting iron supplementation for anemia in dialysis patients--the Basis for Japan's conservative guidelinesHiroyasu Yamamoto, Yoshiharu Tsubakihara
Clinical Calcium|December 4, 2004
[K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients]Noriyuki Okada, Yoshiharu Tsubakihara
Clinical Calcium|March 19, 2005
[Hyperphosphatemia and diet therapy]Noriyuki Okada, Yasumasa Kasai, Yoshiharu Tsubakihara
Nephron|January 30, 2022
Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative DataNanami Kida, Toshitaka Morishima, Yoshiharu Tsubakihara, et al.
Kidney International|August 26, 2004
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patientsTatsuya Shoji, Yoshiharu Tsubakihara, Masamitsu Fujii, et al.
Scientific Reports|February 1, 2017
Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact MatchingYoshitsugu Obi, Takayuki Hamano, Atsushi Wada, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 31, 2012
Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy RegistryKunihiro Yamagata, Shigeru Nakai, Kunitoshi Iseki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2010
Tachycardia as a predictor of poor survival in chronic haemodialysis patientsKunitoshi Iseki, Shigeru Nakai, Kunihiro Yamagata, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 16, 2015
Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patientsKeiichi Sumida, Kunihiro Yamagata, Kunitoshi Iseki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 7, 2015
High Hemoglobin Levels Maintained by an Erythropoiesis-Stimulating Agent Improve Renal Survival in Patients with Severe Renal ImpairmentYoshiharu Tsubakihara, Tadao Akizawa, Manabu Iwasaki, et al.
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Seminars in Dialysis|June 21, 2011
Limiting iron supplementation for anemia in dialysis patients--the Basis for Japan's conservative guidelinesHiroyasu Yamamoto, Yoshiharu Tsubakihara
Clinical Calcium|December 4, 2004
[K/DOQI clinical practice guidelines for management of renal osteodystrophy in predialysis patients]Noriyuki Okada, Yoshiharu Tsubakihara
Clinical Calcium|March 19, 2005
[Hyperphosphatemia and diet therapy]Noriyuki Okada, Yasumasa Kasai, Yoshiharu Tsubakihara
Nephron|January 30, 2022
Stage at Diagnosis and Prognosis of Colorectal, Stomach, Lung, Liver, Kidney, and Bladder Cancers in Dialysis Patients: A Multicenter Retrospective Study Using Cancer Registry Data and Administrative DataNanami Kida, Toshitaka Morishima, Yoshiharu Tsubakihara, et al.
Kidney International|August 26, 2004
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patientsTatsuya Shoji, Yoshiharu Tsubakihara, Masamitsu Fujii, et al.
Scientific Reports|February 1, 2017
Vitamin D Receptor Activator Use and Cause-specific Death among dialysis Patients: a Nationwide Cohort Study using Coarsened Exact MatchingYoshitsugu Obi, Takayuki Hamano, Atsushi Wada, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|March 31, 2012
Late dialysis start did not affect long-term outcome in Japanese dialysis patients: long-term prognosis from Japanese Society for [corrected] Dialysis Therapy RegistryKunihiro Yamagata, Shigeru Nakai, Kunitoshi Iseki, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 7, 2010
Tachycardia as a predictor of poor survival in chronic haemodialysis patientsKunitoshi Iseki, Shigeru Nakai, Kunihiro Yamagata, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 16, 2015
Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patientsKeiichi Sumida, Kunihiro Yamagata, Kunitoshi Iseki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 7, 2015
High Hemoglobin Levels Maintained by an Erythropoiesis-Stimulating Agent Improve Renal Survival in Patients with Severe Renal ImpairmentYoshiharu Tsubakihara, Tadao Akizawa, Manabu Iwasaki, et al.
Pageof 13